Britain First To Approve Booster That Targets Variants

Reuters reports:

Britain has become the first country to approve a COVID-19 vaccine that targets both the original and Omicron variant of the virus.

The the UK medicines regulator (MHRA) approved the so-called bivalent vaccine made by U.S. drug company Moderna as a booster for adults.

The MHRA also cited an exploratory analysis in which the shot was also found to generate a good immune response against the currently dominant Omicron offshoots BA.4 and BA.5.

Read the full article.

(Reuters) – Britain has become the first country to approve a COVID-19 vaccine that targets both the original and Omicron variant of the virus. https://t.co/xb37GlKW0c

— JM Rieger (@RiegerReport) August 15, 2022